Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0000921895-25-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2024-12-31 | HBIO | Green James W | CEO, Dir | D - Sale to Iss | $0.00 | -145.4K | 2.88M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | D | D | 145,365 | $0.00 | 2,883,501 | D | — | — | (F1) Represents forfeiture of performance-based restricted stock units ("RSUs") granted to the Reporting Person on March 1, 2022 based on the final determination of the applicable performance conditions. (F2) Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 1,996,584 shares of common stock beneficially owned by the Reporting Person. |